• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜配合物作为治疗剂。

Copper complexes as therapeutic agents.

机构信息

Centre for Neuroscience & Department of Pathology, The University of Melbourne, Victoria, 3010, Australia.

出版信息

Metallomics. 2012 Feb;4(2):127-38. doi: 10.1039/c2mt00174h. Epub 2011 Dec 20.

DOI:10.1039/c2mt00174h
PMID:22187112
Abstract

The importance of transition metals in biological processes has been well established. Copper (Cu) is a transition metal that can exist in oxidised and reduced states. This allows it to participate in redox and catalytic chemistry, making it a suitable cofactor for a diverse range of enzymes and molecules. Cu deficiency or toxicity is implicated in a variety of pathological conditions; therefore inorganic complexes of Cu have been investigated for their therapeutic and diagnostic potential. These Cu complexes have been shown to be effective in cancer treatment due to their cytotoxic action on tumour cells. Alternatively, Cu complexes can also modulate Cu homeostasis in the brain, resulting in protective effects in several models of neurodegeneration. In other diseases such as coronary heart disease and skin disease, the success of Cu complexes as potential therapeutics will most likely be due to their ability to increase SOD activity, leading to relief of oxidative stress. This review seeks to provide a broad insight into some of the diverse actions of Cu complexes and demonstrate the strong future for these compounds as potential therapeutic agents.

摘要

过渡金属在生物过程中的重要性已得到充分证实。铜(Cu)是一种过渡金属,可以存在于氧化态和还原态。这使其能够参与氧化还原和催化化学,使其成为各种酶和分子的合适辅因子。Cu 缺乏或毒性与多种病理状况有关;因此,人们研究了 Cu 的无机配合物的治疗和诊断潜力。这些 Cu 配合物已被证明在癌症治疗中有效,因为它们对肿瘤细胞具有细胞毒性作用。或者,Cu 配合物还可以调节大脑中的 Cu 动态平衡,从而在几种神经退行性变模型中产生保护作用。在其他疾病(如冠心病和皮肤病)中,Cu 配合物作为潜在治疗药物的成功很可能归因于它们能够提高 SOD 活性,从而缓解氧化应激。本综述旨在提供对 Cu 配合物的一些不同作用的广泛了解,并展示这些化合物作为潜在治疗剂的强大未来。

相似文献

1
Copper complexes as therapeutic agents.铜配合物作为治疗剂。
Metallomics. 2012 Feb;4(2):127-38. doi: 10.1039/c2mt00174h. Epub 2011 Dec 20.
2
Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.硝咪唑和氨基葡萄糖缀合杂环配体及相关铜(II)配合物。合成、生物活性和 XAS 研究。
Dalton Trans. 2011 Oct 14;40(38):9877-88. doi: 10.1039/c1dt10486a. Epub 2011 Jun 28.
3
Mechanisms controlling the cellular accumulation of copper bis(thiosemicarbazonato) complexes.控制铜双(硫代氨基甲酸盐)配合物细胞积累的机制。
Inorg Chem. 2011 Oct 3;50(19):9594-605. doi: 10.1021/ic201334q. Epub 2011 Sep 1.
4
Copper, gold and silver compounds as potential new anti-tumor metallodrugs.铜、金和银的化合物作为有潜力的新型抗肿瘤金属药物。
Future Med Chem. 2010 Oct;2(10):1591-608. doi: 10.4155/fmc.10.234.
5
Complex formation, thermal behavior and stability competition between Cu(II) ion and Cu(0) nanoparticles with some new azo dyes. Antioxidant and in vitro cytotoxic activity.配合物形成、热行为及 Cu(II)离子与一些新偶氮染料的 Cu(0)纳米粒子之间的稳定性竞争。抗氧化和体外细胞毒性活性。
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Apr 15;107:359-70. doi: 10.1016/j.saa.2013.01.039. Epub 2013 Jan 31.
6
Inhibition of respiratory complex I by copper(ii)-bis(thiosemicarbazonato) complexes.铜(II)-双(硫代半卡巴腙)配合物对呼吸链复合体I的抑制作用
Metallomics. 2014 Dec;6(12):2250-9. doi: 10.1039/c4mt00226a. Epub 2014 Nov 4.
7
Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).新型铜配合物作为癌症治疗的潜在蛋白酶体抑制剂(综述)
Mol Med Rep. 2017 Jan;15(1):3-11. doi: 10.3892/mmr.2016.6022. Epub 2016 Dec 9.
8
Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?标题:具有 1:1 与 1:2 型二茂铁基腙配体配位的铜(I)和镍(II)配合物:配合物的几何形状和组成是否会影响 DNA 结合/切割、蛋白质结合、抗氧化和细胞毒性活性?
Dalton Trans. 2012 Apr 21;41(15):4423-36. doi: 10.1039/c2dt11938b. Epub 2012 Feb 17.
9
Radical production by hydrogen peroxide/bicarbonate and copper uptake in mammalian cells: modulation by Cu(II) complexes.过氧化氢/碳酸氢盐产生的自由基和铜在哺乳动物细胞中的摄取:Cu(II)配合物的调节。
J Inorg Biochem. 2011 Feb;105(2):189-94. doi: 10.1016/j.jinorgbio.2010.10.017. Epub 2010 Nov 6.
10
Anti-thyroid and antifungal activities, BSA interaction and acid phosphatase inhibition of methimazole copper(II) complexes.他巴唑铜(II)配合物的抗甲状腺和抗真菌活性、BSA 相互作用及酸性磷酸酶抑制作用。
Chem Biol Interact. 2015 Mar 5;229:64-72. doi: 10.1016/j.cbi.2014.12.036. Epub 2015 Jan 29.

引用本文的文献

1
Targeting dysregulated molecular pathways in cancer cell lines using small molecule inhibitors as a promising therapeutic strategy.使用小分子抑制剂靶向癌细胞系中失调的分子途径作为一种有前景的治疗策略。
Sci Rep. 2025 Jul 7;15(1):24273. doi: 10.1038/s41598-025-06892-z.
2
Chromium-histidine complex enhances reproductive physiology and development in Drosophila melanogaster by modulating oxidative stress.铬-组氨酸复合物通过调节氧化应激来增强黑腹果蝇的生殖生理和发育。
Biometals. 2025 Feb;38(1):321-335. doi: 10.1007/s10534-024-00656-4. Epub 2024 Dec 16.
3
Trends of Copper Homeostasis in Neoplasms: A Systemic Bibliometric from 2013 to 2023.
肿瘤中铜稳态的趋势:2013年至2023年的系统文献计量学分析
Biol Trace Elem Res. 2025 Jun;203(6):3445-3454. doi: 10.1007/s12011-024-04413-z. Epub 2024 Oct 9.
4
Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides-Current Developments in Structure-Activity Relationship.金属药物和金属化宿主防御肽的抗癌活性-结构-活性关系的最新进展。
Int J Mol Sci. 2024 Jul 3;25(13):7314. doi: 10.3390/ijms25137314.
5
Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands.含三联吡啶和PTA配体的新型水溶性铜(I)配合物的设计、合成及抗癌评估
Molecules. 2024 Feb 21;29(5):945. doi: 10.3390/molecules29050945.
6
Promising 8-Aminoquinoline-Based Metal Complexes in the Modulation of SIRT1/3-FOXO3a Axis against Oxidative Damage-Induced Preclinical Neurons.基于8-氨基喹啉的有前景的金属配合物对SIRT1/3-FOXO3a轴的调节作用以对抗氧化损伤诱导的临床前神经元。
ACS Omega. 2023 Nov 30;8(49):46977-46988. doi: 10.1021/acsomega.3c06764. eCollection 2023 Dec 12.
7
How the Presence of Crystalline Phase Affects Structural Relaxation in Molecular Liquids: The Case of Amorphous Indomethacin.晶相的存在如何影响分子液体的结构弛豫:以无定形吲哚美辛为例。
Int J Mol Sci. 2023 Nov 13;24(22):16275. doi: 10.3390/ijms242216275.
8
Design of the elusive proteinaceous oxygen donor copper site suggests a promising future for copper for MRI contrast agents.设计难以捉摸的蛋白质氧供体铜位点为铜基 MRI 对比剂的发展提供了广阔的前景。
Proc Natl Acad Sci U S A. 2023 Jul 4;120(27):e2219036120. doi: 10.1073/pnas.2219036120. Epub 2023 Jun 26.
9
Coordination Compounds of Cu, Zn, and Ni with Dicarboxylic Acids and N Donor Ligands, and Their Biological Activity: A Review.含 Cu、Zn、Ni 的配位化合物与二羧酸和 N 供体配体的配位化合物及其生物活性:综述。
Molecules. 2023 Feb 2;28(3):1445. doi: 10.3390/molecules28031445.
10
Synthesis, Structural Characterization and Biological Activity Evaluation of Novel Cu(II) Complexes with 3-(trifluoromethyl)phenylthiourea Derivatives.新型 3-(三氟甲基)苯硫脲衍生物与 Cu(II) 配合物的合成、结构表征及生物活性评价。
Int J Mol Sci. 2022 Dec 10;23(24):15694. doi: 10.3390/ijms232415694.